EMA: Brexit-Q&A to the prevention of medicine shortages
EMA has published a 3-page questions-and-answers document (Q&A) on the work that the EU authorities are doing to prevent medicine shortages due to the United Kingdom’s withdrawal from the EU.
It explains that in case of a withdrawal agreement, there will be a transition period during which EU law will continue to apply in the United Kingdom. This means that access to medicines will not be affected.
The Q&As apply to both human and veterinary medicines and will be updated as necessary.
Our website uses cookies. This includes cookies that are technically necessary for the proper operation of the site,
as well as cookies that are used for statistical purposes, for comfort settings or to display personalized content.
You can decide for yourself which categories you want to allow. Please note that, based on your settings, not all functionalities of the site may be available.
For more information, please see our data privacy statement and our cookie policy.
Necessary
These cookies are absolutely necessary for the proper operation of the site and enable, for example, security-related functionalities.
In addition, we can also use this type of cookie to recognize whether you wish to remain logged in to your profile
in order to make our services available to you more quickly when you visit our site again.
Statistics
To further improve our offer and our website, we collect anonymous data for statistics and analysis.
With the help of these cookies we can, for example, determine the number of visitors and the effect of certain pages
of our website and optimise our content.
No comment has yet been written about this news
Write your comment about this news